Arkolith/Insider Trading/TXG/Form 4

Saxonov Serge

Chief Executive Officer, Director10x Genomics, Inc. (TXG) · full profile →Form 4 · filed Jan 18, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$181K
Net Open-Market Flow
-$181K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 16, 2024Sell(S)1K$45.65$47K856K
Jan 16, 2024Sell(S)3K$45.10$134K857K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-24-000030) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML